Revolutionising Cancer Treatment with AI & Nanotechnology
Cancer Cases every year
Chemotherapy Patients
Oncology market size in 2030
Pioneering Advancements
Our protein-based nanoparticle delivery systems responds to...
ATP and pH for precise drug release, ensuring targeted efficacy while minimising side effects.
With disease-specific targeting mechanisms, versatile drug loading for therapeutics like Doxorubicin, and atomic-level structural precision, our technology enables enhanced engineering for superior cancer treatment.
Side effects experienced by patients...
%
Fatigue
%
Peripheral Neuropathy
%
Hair Loss
%
Liver Damage
%
Mucositis
%
Kidney Damage
%
of patients going through chemo experience significant side effects
%
fewer drugs required with Prosemble technology
%
of medicine currently gets to the tumours
Through Our Science We Are Transforming Cancer Treatment for Chemotherapy Patients
Latest News
Newly identified bacterial protein
A nice summary of our discovery, and how we are using it at Prosemble, from our “parent” institution,
Cambridge AI Demo Day
On Thursday, 13th March, Prosemble is honoured to be part of a select group of AI startups presenting at the very first Cambridge AI Demo Day. To put things into perspective:
AI in Health Accelerator Programme Pitch
5th of March marked the final pitch day for as part of Prosemble AI in Health Accelerator Programme. Over the past eight weeks, we’ve taken a deep dive into customer discovery